Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-03-08-Speech-2-259-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110308.22.2-259-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"I would like to congratulate Mrs Rivasi for her excellent work. This report is an important attempt to highlight the doubts that have been raised over the disproportionate response to swine flu in Europe, as well as the potential influence of pharmaceutical companies on the actions taken.
I am critical of the EU's response in 2009-2010 to ‘swine flu’, the H1N1 virus. I suggest, for the future, group purchasing of vaccines to save money and more effective rules to prevent conflicts of interest, for example, by publishing the declaration of interests of experts who advise European health authorities. In this regard, I note that according to European legislation, liability for vaccines lies with manufacturers and not national governments.
I also call on the World Health Organisation (WHO) to revise the definition of ‘pandemic’ and also take into account the virulence of the disease and not only the geographical spread of the virus. In order to provide the Union with its own capacity to prevent risks of a pandemic, the European Centre for Disease Prevention and Control (ECDC) must be guaranteed the support it needs to perform this task entirely independently."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples